Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 151–200 of 1,389 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05721326	Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition	completed	N/A	1,283	Abramson Cancer Center at Penn MedicineOTHER	1	Jun 17, 2026	clinicaltrials
NCT06543537	Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer	recruiting	N/A	112	Dana-Farber Cancer InstituteOTHER	1	Jun 17, 2026	clinicaltrials